- Staat
- NC
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 20.04.2023
- Impfdatum
- 19.04.2023
- Beginn
- 19.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Body temperature decreased
Cold sweat
Fatigue
Pallor
Tonic convulsion
Symptomtext
Approximately 2 minutes after receiving vaccines, at 10:35am, while sitting in parent's lap, pt had what appeared to be a tonic seizure x 10 seconds. Pt did not sustain any injuries before/during/after seizure. Immediately following seizure, pt was able to state his name, squeeze his mother's hand when prompted, and nod in agreement to questions. Pt was alert and oriented but fatigued, stated he didn't want to sit up because he was tired. Per parent, pt did eat breakfast that morning. Pt appeared pale and clammy. Manual BP was taken (82/62 right arm, sitting) and temp (96.3 oral), slightly decreased. Snacks and juices given, which pt consumed readily. Pt complained of nausea for a few minutes and then resolved. Parent was given information for ED and nearby urgent cares, and offered to call EMS. Parent declined. After about 40 minutes in observation pt was standing and walking around, color returned, speaking regularly. BP taken again, improved (96/70). Parent called pediatrician and set up appt for 4pm same day. Pt ambulated out of clinic with parent, alert, oriented, and steady on feet. Per parent, pt had appt with pediatrician same day as event at 4pm, physical exam was within normal limits. No testing was done. Pt has appt scheduled with neurology in 2 weeks.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tonic convulsion
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- Seizure following COVID Moderna BV on 11/11/22. Per mother it was longer. Pt was seen by neurologist and cleared to receive vac
- Staat
- MO
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 06.04.2023
- Impfdatum
- 06.04.2023
- Beginn
- 06.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Syncope
Symptomtext
Patient fainted and lost consciousness for multiple seconds.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Birth control
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 20.02.2023
- Impfdatum
- 20.02.2023
- Beginn
- 20.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Consciousness fluctuating
Loss of consciousness
Seizure
Symptomtext
gave typhoid and covid booster first. when giving yellow fever patient said [he didn't like that one] Upon completion, patient passed out and started seizing. Called 911. He came to for a little bit, then passed out again. Layed him down and elevated feet. EMS arrived and performed vitals. He was taken in for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 06.02.2023
- Impfdatum
- 03.02.2023
- Beginn
- 03.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Epistaxis
Injection site pain
Pallor
Posture abnormal
Syncope
Urinary incontinence
Symptomtext
Patient was given Yellow Fever vaccine on Right Arm followed by Pfizer bivalent booster on the Left Arm. We were discussing oral Typhoid vaccine and she stated she was feeling light-headed. Her mother remarked she her face was very pale. Patient was sitting in a chair and slumped over. I believe she experienced vasovagal syncope. She remained seated after coming out of it. Unfortunately, she did lose control of her bladder as she came out of it. Mom stated her daughter had never fainted before with vaccines. She remained seated and drank a Capri Sun. She was feeling better when they left. 2/6/2023 9:00 am. Follow up call to mom-mom states her daughter did have a sore arm where Pfizer bivalent had been given. She also reports her daughter had 3 bloody noses the next day on 2/4/2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- None
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 01.08.2023
- Impfdatum
- 01.03.2023
- Beginn
- 01.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Allergy to vaccine
Anion gap
Blood calcium normal
Blood chloride normal
Blood creatinine normal
Blood glucose normal
Blood osmolarity decreased
Blood potassium normal
Blood sodium normal
Blood urea normal
Carbon dioxide normal
Chest discomfort
Dyspnoea
Eosinophil count
Glomerular filtration rate
Haematocrit decreased
Haemoglobin decreased
Lymphocyte count
Symptomtext
Per ED note: Patient here for possible allergic reaction. Brought in by EMS. Patient reports a history of asthma, last major symptoms were around age 10 or 11. States that about an hour prior to calling EMS he had preemployment vaccinations. Computer records indicate that these included anthrax, Japanese encephalitis, typhoid and yellow fever. He was feeling normal before the vaccination but about an hour later he started to feel short of breath and had some vague right-sided chest discomfort. EMS was called and noted that his oxygen sat was around 90% and that he was wheezing apparently. They administered Solu-Medrol 125 mg, Benadryl 25 mg and a DuoNeb. The shortness of breath and wheezing completely resolved. Patient still describes some vague right-sided discomfort of the chest. He has no other symptoms. Denies any swelling of the lips, tongue, throat, difficulty breathing or swallowing. No vomiting. No nausea. No history of similar reaction. 11:16 -patient evaluated after EMS arrival. Sent here is 98-99% on room air. Lung exam and rest of physical exam completely normal at this time. We will continue to monitor. Do not feel any new or other medication required at this time. 1323: Patient has been largely asymptomatic throughout ED course. Sleeping most of the time. He woke up now states he feels back to normal except he noticed that his upper back is a little bit itchy. On exam the upper portion of his back has a few small urticarial lesions. Nothing extensive and no others patches on his body. Will give extra Benadryl and continue to observe. 1453: Patient rechecked and doing well. No symptoms. No itching. No significant rash. Patient has been observed here for several hours without significant changes or signs of anaphylaxis. Will give prescriptions for prednisone, Benadryl, EpiPen, albuterol inhaler. Patient instructed on use of the medications. Patient to follow-up with PCM. Also, I spoke with Dr. from allergy clinic. We will follow-up as a routine consult for specific testing for allergy to vaccine components. Nurse to list vaccines under his allergy list in the meantime.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- 3/1/23: BP 124/72, HR 91, RR 20. Na 137, K 4, Cl 100, CO2 27, AGAP 10, Osmo 276, BUN 17, SCr 1.2, eGFR 90, Glu 110, Ca 9.9 WBC 4.8, Hbg 13.9, Hct 40.9, Plt 176, Abnormal Neutrophil 39.5, lympocytes 46.5, eosinophil 8.1
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- History of childhood asthma, last issues at age 10-11
- Andere Medikamente
- No medications
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 02.03.2023
- Impfdatum
- 21.02.2023
- Beginn
- 23.02.2023
- Tage bis Beginn
- 2,0
- Dosis
- UNK
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Chest X-ray
Mobility decreased
Musculoskeletal pain
Symptomtext
Severe pain in upper left back. Around the shoulder blade (not the shoulder). Needed to lay down to relieve pain, could not sit/stand for any length of time. Went to see a walk-in clinic doctor on 2/24/2023. Told them the pain was 8 out of 10. Was prescribed methocarbamol, lidocaine/prilocaine cream, naproxen and given a shot of tramadol. Severe back pain continued. Went to see PCP on 2/27/2023, told her the pain was 7 out of 10 and was told to continue to use prescriptions and try to rest back as much as possible. Some improvement after staying mostly in bed through 3/1/2023. Needed to do some things on 3/2/2023 and pain level was between 5-7. The longer sitting or standing the higher the pain level goes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- Chest x-ray, 2/27/2023.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- type II diabetes depression breast cancer 2021; radiation completed 2/22/22
- Andere Medikamente
- Effexor, hydrochlorothiazide, insulin, brupropian hcl, trulicity, tart cherry, claritin, exemestane
- Allergien
- sulfa neomyacin, bacitracin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 19.07.2023
- Impfdatum
- 18.07.2023
- Beginn
- 18.07.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Abdominal tenderness
Cardiac function test
Chest discomfort
Oxygen saturation decreased
Pruritus
Pulmonary function test normal
Urticaria
Symptomtext
Initial exam was significant for normal vital signs, urticaria to back, neck and left forearm. Mild tenderness to palpation to LLQ. No oral edema was appreciable, pulmonary exam without wheezing, cardiac exam with RRR. Initial epi pen was administered. Patient continued to endorse worsening urticaria and itch as well as chest tightness and second dose of epinephrine was administered approximately 8 minutes later. His oxygen levels dropped to the 92-94% so supplemental O2 was initiated via a non rebreather. On transfer to EMS team, patient was in stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- ADHD, Hyperlipidemia
- Andere Medikamente
- Ibuprofen, cyclobenzaprine, naproxen, topical lidocaine patches
- Allergien
- shellfish, iodine
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 11.05.2023
- Impfdatum
- 05.05.2023
- Beginn
- 08.05.2023
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site pain
Injection site pruritus
Peripheral swelling
Pyrexia
Symptomtext
Swelling and redness to back of left arm. Patient states he has had fever after receiving vaccine but took OTC Tylenol and symptoms resolved. Patient states swelling has increased to left arm and complains of soreness and itching to site. Patient advised to be seen at Emergency Department. Patient states he has appointment with PCM and will have site examined.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Lisinopril, Sulfa-Drugs
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 09.05.2023
- Impfdatum
- 07.04.2023
- Beginn
- 19.04.2023
- Tage bis Beginn
- 12,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Cough
Diarrhoea
Fatigue
Headache
Heart rate increased
Immunisation reaction
Laboratory test
Loss of personal independence in daily activities
Malaise
Pain
Pyrexia
Urine analysis
Symptomtext
4/19/23 8:25 AM Incoming call from patient, he states he is have sx of fever (103T), chills, head ache, increased HR (107bpm), body aches, fatigue, diarrhea ( last bm was yesterday and looste). Denies n/v, SOB, or chest pain. Patient is calling his PCP for appointment. Advised per RN, for patient to see PCP today and to let us know what his doctor says and we will follow up Prn. Patient was administered YF vax 4/7/2023 and called initially with sx on 4/14/2023, with todays follow up of sx as mentioned above. 4/19/23 9:12 AM Outgoing caall to patient, to follow up on appointment status with PCP. Patient state he has appointment with PCP at 2pm today 4/19/2023. Advised patitient I will follow up with him at 3;30pm today. 4/19/23 3:00 PM no answer , left voicemail 4/19/23 3:43 PM outgoing vall at 3pm to follow up, no answer, left voicemail for patient to call back. Called again 3:40 PM.04/19/23- no answer, left voicemail for pt to call back for follow up post PCP visit. Left call back number. 4/19/23 4:04 PM At 3:49pm 04/19/23, incoming call from patient, he states he saw his PCP, states labs were ordered , UA done patient states he was assessed and Dr believes he was having reaction to YF vax and "not worried about it" ( the sx), states he was given RX for steroids, states he will start today. Patient states he is taking both tylenol and Aleve for fever. Advised patient to call back prn and that I will be following up with him everyday until labs resulted. 04/20/23 3:52 PM Outgoing call to patient, he states he feeling better, no fever, currently taking steroid rx from PCP . States he has h/a when coughing and continued fatigue. Patient states he is flying out of town ( unk destination). Advised him that either I or RN will be available for follow up. Understanding verbalized. No further questions or concerns at this time. Call terminated. 4/27/23 7:46 AM Outgoing call , spoke with patient, he states he saw his PCP yesterday as he is continuing to have a 10-102 fever, body aces and chills; denies any upper respiratory involvement. He states his pcp advised him antipyretic use prn. He is waiting results of more lab work. No records received yet from pcp. 5/2/23 3:54 PM Incoming email from paitent "I wanted to let you know that I am still very sick and will be canceling my trip. It is possible I will need something from you for my insurance claim - I will let you know. This is a doozy. Please do warn your over 60+ patients about my experience. Have you reported everything you needed to the CDC? If someone there is available to talk to me, that would be great." Outgoing call, no answer, left vm for pt to call back.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- See attached.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- psoriatic arthritis, asthma
- Andere Medikamente
- VEONTOLIN IN Amlodipine Besylate ASPIRIN Atorvastatin Calcium Malarone Malarone Azithromycin Vitamin D CLOBEX EX CLOBETASOL PROPIONATE EX EPIPEN IM Finasteride FLUTICASONE PROPIONATE Fluticasone-Salmeterol FOLIC ACID Methotrexate Sodium Ome
- Allergien
- Penicillins Hives Ciprofloxacin Hcl Nsaids Hives
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 03.05.2023
- Impfdatum
- 14.04.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pruritus
Injection site swelling
Injection site warmth
Symptomtext
swelling on the injection site; The area is red and warm to touch; It also itched in the beginning but is now light pink.; The area is red and warm to touch; Initial information received on 21-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2023SA128665 and 2023SA130929. This case involves a 17 years old female patient who experienced swelling on the injection site, the area is red and warm to touch, it also itched in the beginning but is now light pink while receiving vaccine Yellow Fever Vaccine [YF-VAX]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 14-Apr-2023, the patient received at dose 0.5 ml at standard strength of suspect Yellow Fever Vaccine(lot: UJ782AA, Expiry date: 17-Feb-2024) via subcutaneous route in unknown administration site for Prophylactic Vaccination (Immunization). On an unknown date the patient developed swelling on the injection site (vaccination site swelling), the area is red and warm to touch (vaccination site erythema) & (vaccination site warmth) and it also itched in the beginning but is now light pink. (pruritus) (unknown latency) following the administration of Yellow Fever Vaccine. Action taken: not applicable. It was not reported if the patient received a corrective treatment for all the events. At time of reporting, the outcome was Unknown for all the events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 14.04.2023
- Beginn
- 14.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Limb discomfort
Pruritus
Symptomtext
the next day worsen itchy redder cream; condition worsened; arms have rxns; Initial information was received on 21-Apr-2023 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 49 years old female patient who experienced arms have rxns and the next day worsen itchy redder cream after being vaccinated with yellow fever vaccine [YF-vax]. The patient's past medical history, medical treatment(s), concomitants, vaccination(s) and family history were not provided. On 14-Apr-2023, the patient received a dose of 0.5 ml total suspect yellow fever vaccine Solution for injection (strength: standard) (lot number: UJ782AA, expiration date: 17-Feb-2024) via subcutaneous route in unknown administration site for Immunization (immunization). On 14-Apr-2023 the patient developed a non-serious event of "arms have rxns" (limb discomfort) same day following the administration of yellow fever vaccine. On 15-Apr-2023 the patient developed a non-serious the next day "worsen itchy redder cream" (pruritus) and condition worsened (condition aggravated) 1 day following the administration of yellow fever vaccine. No lab data reported. Action taken: not applicable. A redder cream as corrective treatment was received for the events (condition worsened, the next day worsen itchy redder cream). It was not reported if the patient received a corrective treatment for the event (arms have rxns). Outcome: Recovered / Resolved on an unknown date for the event arms have rxns and was Recovering / Resolving for the event the next day worsen itchy redder cream.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 14.04.2023
- Impfdatum
- 12.04.2023
- Beginn
- 13.04.2023
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site swelling
Lymph node pain
Lymphadenopathy
Symptomtext
local reaction to left arm at injection site (erythema, swelling, pain) with significant painful left sided axillary lymphadenopathy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- ozempic, zyrtec, flonase
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 02.03.2023
- Impfdatum
- 01.03.2023
- Beginn
- 01.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Allergy to vaccine
Cough
Hypersensitivity
Pruritus
Rash
Rash erythematous
Rash pruritic
Throat irritation
Urticaria
Symptomtext
Per notes from medical provider: ?HPI Patient comes in for evaluation of rash. Onset of rash 315. Had just received immunizations including COVID booster, yellow fever, typhoid and flu vaccine 215. Rash is itchy and red. Rash is generalized and spread to his chest back arms neck abdomen and legs. Rash is itchy. States his throat feels irritated and scratchy. States he did have nausea but that is better. Denies chest pain or airway closure. States he did take some ibuprofen. He denies body aches, headache, syncope. Denies history of allergic reactions to vaccines in the past. Mother accompanies patient here in the clinic. Allergic Reaction This is a new problem. The current episode started today. The problem occurs daily. The problem has been rapidly worsening since onset. Associated symptoms include coughing (dry) and a rash. Pertinent negatives include no abdominal pain, chest pain, eye itching, eye redness, stridor, trouble swallowing, vomiting or wheezing. There is no history of food allergies. Encounter Diagnoses -T80.69XA Allergic reaction to vaccine -L50.9 Hives -L29.9 Pruritus Patient was seen today for allergic reaction. Diagnoses and all orders for this visit: Allergic reaction to vaccine - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Educated mother she can give another Benadryl 25 mg if needed. Educational handout given on medications. Educated on EpiPen. If airway closure did educate on administration of EpiPen and to go to the ER immediately or call 911. Mother in agreement with plan and verbalized understanding. Hives - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min Pruritus - methylPREDNISolone sodium succinate(PF) (SOLU-MEDROL) injection 40 mg - diphenhyrAMINE (Benadryl) capsule 25 mg - famotidine (PF) (Pepcid) injection 10 mg - EPINEPHrine (EPIPEN) 0.3 mg/0.3 ML Atln; Inject 0.3 mLs (0.3 mg total) into muscle 1 (one) time a day as needed (anaphylaxis). Or subcutaneous. May repeat does x 1 after 5-15 min?
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- no known illnesses
- Vorgeschichte
- Irregular heart beat Premature ventricular contractions Ventricular trigeminy Trigeminy
- Andere Medikamente
- cetirizine (ZYRTEC) 10 mg EPINEPHrine (EPIPEN) 0.3mg/0.3 mL Atln fluticasone propionate (FLONASE) 50 mcg/actuation nasal spray
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 07.02.2023
- Impfdatum
- 24.01.2023
- Beginn
- 25.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pruritus
Injection site swelling
Symptomtext
itchiness, swelling and redness at injection site
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- apple
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 30.01.2023
- Impfdatum
- 23.01.2023
- Beginn
- 24.01.2023
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site pain
Peripheral swelling
Pruritus
Symptomtext
right arm has been red, swollen, itchy, and slightly painful at the site of my YF vaccine, approximately 5-6cm in size
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- Recommended ice, motrin and observation
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Isolated premature ventricular contractions
- Andere Medikamente
- JUNEL FE 1/20, 28, 1 mg-20 mcg (21)/75 mg (7) per tablet
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 25.05.2023
- Impfdatum
- 25.05.2023
- Beginn
- 25.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Ear discomfort
Eye swelling
Lip swelling
Pharyngeal swelling
Symptomtext
Pt arrived at health unit asking to receive a Yellow Fever vaccine as he was going to another country. He had just left the Clinic 15 minutes prior and had received a Typhoid vaccine. After researching interactions between getting both vaccines in one day, the yellow fever vaccine was administered. Approximately 1 hour after receiving the Typhoid Vaccine we administrated the Yellow Fever vaccine. Allergies were reviewed. Asked specifically if patient was allergic to Eggs, Chicken or Gelatin. Patient verbalized he was not allergic to any of those items. Pt states 15 minutes after leaving the Unit, his throat started swelling, felt pressure in his ears, eyes were swollen and lips were swelling. Patient reports he went home and took a nebulizer treatment. Patient reports he then drove himself to ER. Patient reports he was given Benadryl IM, a steroid IM and Pepcid. He was given a prescription of oral steroids and Pepcid. Patient called at 3:00 pm to report VAERS and stated he was feeling better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ear discomfort
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma
- Andere Medikamente
- Singulair
- Allergien
- Peanuts, Shellfish
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 16.05.2023
- Impfdatum
- 11.05.2023
- Beginn
- 11.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product use issue
Symptomtext
Patient was already immune to HEP B and received Hepislav-B
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product use issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 11.05.2023
- Impfdatum
- 11.05.2023
- Beginn
- 11.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenopia
Capillary nail refill test abnormal
Cold sweat
Lethargy
Symptomtext
Patient became lethargic about 3 minutes after receiving vaccine. Patient could not keep eyes open but did not lose consciousness. Patient slow to answer questions. Skin was cold, clammy, capillary refill was sluggish. Patient placed in reclined position in parent's lap with feet elevated. Epi-Pen given by RN about one minute after initial assessment. Child was responsive to pain from EpiPen and symptoms improved. About 10 minutes later, child was evaluated by PA & deemed safe to return home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenopia
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 06.05.2023
- Impfdatum
- 24.02.2023
- Beginn
- 24.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product preparation error
Symptomtext
reconstituted with 0.7mL sterile diluent provided by Merck and meant for Merck live virus reconstitution, rather than 0.6mL Sodium Chloride solution with no reported adverse event; Initial information received on 02-May-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 45 years old male patient who received yellow fever vaccine - [YF-VAX] reconstituted with 0.7ml sterile diluent provided by merck and meant for merck live virus reconstitution, rather than 0.6ml sodium chloride solution with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 24-Feb-2023, the patient received an unknown dose of suspect yellow fever vaccine - , solution for injection (lot: UJ782AA; expiry date: 17-Feb-2024) via subcutaneous route in the left arm for prophylactic vaccination (immunization) reconstituted with 0.7ml sterile diluent provided by merck and meant for merck live virus reconstitution, rather than 0.6ml sodium chloride solution with no reported adverse event (product preparation error) (same day latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event reconstituted with 0.7ml sterile diluent provided by merck and meant for merck live virus reconstitution, rather than 0.6ml sodium chloride solution with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 05.05.2023
- Impfdatum
- 28.02.2023
- Beginn
- 28.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
Yellow Fever Vaccine which may have been reconstituted with 0.7mL sterile diluent provided by Merck and meant for Merck live virus reconstitution, rather than 0.6mL Sodium Chloride solution with no reported adverse event; Administered IM in lieu of SQ as directed with no reported adverse event; Initial information received on 02-May-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 24 years old female patient who experienced Yellow Fever Vaccine - [YF-VAX] which may have been reconstituted with 0.7ml sterile diluent provided by merck and meant for merck live virus reconstitution, rather than 0.6ml sodium chloride solution and administered IM in lieu of SQ as directed with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor. On 28-Feb-2023, the patient received a dose of suspect Yellow Fever Vaccine -solution for injection which may have been reconstituted with 0.7ml sterile diluent provided by merck and meant for merck live virus reconstitution, rather than 0.6ml sodium chloride solution (lot: UJ782AA) via intramuscular route in lieu of SQ as directed in unknown administration site for prophylactic vaccination with no reported adverse event (product preparation error) and (incorrect route of product administration) (latency: same day). It is unknown if the patient experienced any additional symptoms/events. It is unknown if there were lab data/results available. Action taken: not applicable. At time of reporting, the outcome was Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 05.05.2023
- Impfdatum
- 07.03.2023
- Beginn
- 07.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product storage error
Symptomtext
vaccine which may have been reconstituted with 0.7mL sterile diluent provided by merck and meant for merck live virus reconstitution, rather than 0.6mL Sodium Chloride solution provided by sanofi pasteur no reported adverse event; Initial information received on 02-May-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 20 years old male patient who experienced vaccine which may have been reconstituted with 0.7ml sterile diluent provided by merck and meant for merck live virus reconstitution, rather than 0.6ml sodium chloride solution provided by sanofi pasteur no reported adverse event while receiving vaccine Yellow Fever Vaccine - [YF-VAX]. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor. On 07-Mar-2023, the patient received a dose of suspect Yellow Fever Vaccine, solution for injection which may have been reconstituted with 0.7ml sterile diluent provided by merck and meant for merck live virus reconstitution, rather than 0.6ml sodium chloride solution provided by sanofi pasteu (lot: UJ782AA) via subcutaneous route in unknown administration site for Prophylactic vaccination with no reported adverse event (product preparation error). It is unknown if the patient experienced any additional symptoms/events. It is unknown if there were lab data/results available. Action taken: not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 03.05.2023
- Impfdatum
- 14.04.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immunisation reaction
Symptomtext
adverse reactions on their arms after YF-VAX administration; Initial information was received on 21-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 18 years old female patient who reported that adverse reactions on their arms after yf-vax administration while receiving vaccine yellow fever vaccine [Yf-Vax]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included typhoid vaccine (TYPHOID) for Prophylactic vaccination. On 14-Apr-2023, the patient received a dose of 0.5 ml of suspect yellow fever vaccine (Solution for injection) (lot UJ782AA, Expiry date : 17-Feb-2024) (with unknown strength) via subcutaneous route in unknown administration site for Immunization. On an unknown date the patient developed a non-serious event of adverse reactions on their arms after yf-vax administration (adverse reaction) (unknown latency) following the administration of yellow fever vaccine. Action taken with yellow fever vaccine (Yf-Vax) was not applicable. It was not reported if the patient received a corrective treatment for the event (adverse reactions on their arms after Yf-Vax administration). At time of reporting, the outcome was Recovered on an unknown date for the event adverse reactions on their arms after yf-vax administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immunisation reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 27.04.2023
- Impfdatum
- 24.02.2023
- Beginn
- 24.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
Client was vaccinated with Yellow Fever Vaccine which may have been reconstituted with 0.7 mL sterile diluent provided by Merck and meant for Merck live virus reconstitution, rather than 0.6 mL Sodium Chloride solution provided by Sanofi Pasteur specifically for YF-Vax.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- none known; client travelling from 2/28/2023 through unknown date of return. Client has not responded to phone calls or letter sent in mail
- Aktuelle Erkrankungen
- denied at time of appointment
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- denied at time of appointment
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 28.02.2023
- Beginn
- 28.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
Client was vaccinated with Yellow Fever Vaccine which may have been reconstituted with 0.7 mL sterile diluent provided by Merck and meant for Merck live virus reconstitution, rather than 0.6 mL Sodium Chloride solution provided by Sanofi Pasteur. Vaccine may have been injected IM rather than subcutaneously as directed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- none-client was traveling from 3/12/2023-04/20/2023 and we have not been successful in communicating with this client after several attempts
- Aktuelle Erkrankungen
- denied at time of clinic appointment
- Vorgeschichte
- denied at time of clinic appointment
- Andere Medikamente
- unknown
- Allergien
- denied at time of clinic appointment
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 24.04.2023
- Impfdatum
- 04.04.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product use issue
Symptomtext
No adverse event client is fine Talked with her 4/18/2023 - she had no problems. Event is being reported because I gave live Yellow Fever when client was Receiving Dupixent - every 2 weeks - she called her Dr and Dupixent treatment did not need to be delayed
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- Asthma
- Andere Medikamente
- Trelegy inhaler Dupixent - injection every other week
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 19.04.2023
- Impfdatum
- 18.04.2023
- Beginn
- 18.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
Administered Yellow Fever vaccine via Intramuscular route in error. Correct administration route is subcutaneous. Observed patient for 30 minutes. Tolerated vaccine well. No adverse affect noted. Advised to hydrate and take tylenol or ibuprofen for discomfort
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 19.04.2023
- Impfdatum
- 18.04.2023
- Beginn
- 18.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Discomfort
Incorrect route of product administration
Symptomtext
Vaccine administered via Intramuscular route in error at 3:20. The correct administration is Subcutaneous. Patient observed for 30 minutes. Vaccine tolerated well. Pt advised to hydrate and take tylenol or Ibuprofen for discomfort
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Discomfort
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- No Prescriptions
- Allergien
- Sulfa antibiotics - hives
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 30.03.2023
- Impfdatum
- 07.03.2023
- Beginn
- 07.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product preparation error
Symptomtext
Yellow Fever Vaccine was reconstituted using wrong Sterile Diluent of 0.7 mL vial for MERCK, for LIVE VIRUS VACCINES (sterile water) without preservatives. Sterile diluent provided with vaccines should have been used to reconstitute: Sodium Chloride 0.9%, 0.6 mL Injection USP For reconstitution of single-dose Yellow Fever Vaccine by SANOFI PASTEUR Client declined having any adverse event after this vaccination. Immunizations specialists have advised to re-vaccinate using proper diluent in 28 days after vaccination error occurred in order to provide client with proper coverage.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Client states he had wisdom teeth removed middle of February. Client states he took steroids after having wisdom teeth removed.
- Vorgeschichte
- Client reports traumatic brain injury at age 19-20 years of age, states he had a concussion at that time.
- Andere Medikamente
- none
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.03.2023
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product preparation error
Symptomtext
reconstituted with the incorrect diluent of sterile water instead of the supplied 0.6 mL Sodium Chloride, with no reported adverse event; Initial information received on 22-Mar-2023 regarding an unsolicited valid non-serious case received from Non-Healthcare Professional. This case involves two patients (demographics unknown) for whom YELLOW FEVER VACCINE [YF-VAX], reconstituted with the incorrect diluent of sterile water instead of the supplied 0.6 ml sodium chloride, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect YELLOW FEVER VACCINE Solution for injection (strength, route: unknown) (lot number: UJ782AA, expiry date: 17-Feb-2024) (Sodium chloride Diluent lot: U7056AA Expiry date: Oct-2024) in unknown administration site for Immunization and it was reconstituted with the incorrect diluent of sterile water instead of the supplied 0.6 ml sodium chloride, with no reported adverse event (product preparation error) (unknown latency). It was reported, caller is wanting to know next steps to take. Caller does not have patient's information at time of call. This situation is reported as a medication error due to two patients being administered YF-VAX that was reconstituted with sterile water instead of the supplied diluent. Action taken with YELLOW FEVER VACCINE (YF-VAX) was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 18.02.2023
- Impfdatum
- 10.02.2023
- Beginn
- 10.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Poor quality product administered
Product preparation error
Symptomtext
YF-VAX was administered after it was mixed with sterile water instead of the diluent provided with no reported adverse event; YF-VAX was administered after it was mixed with sterile water instead of the diluent provided with no reported adverse event; Initial information received on 14-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 68 years old male patient was administered Yellow fever vaccine (yf-vax) after it was mixed with sterile water instead of the diluent provided with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Typhoid vaccine live oral (ty21a) (VIVOTIF) for Prophylactic vaccination. On 10-Feb-2023, the patient received suspect Yellow fever vaccine - Solution for injection at dose of 0.5 ml (strength were not provided) (lot UJ782AA and expiry date-17-Feb-2024) via intramuscular route in the left deltoid for immunization after it was mixed with sterile water instead of the diluent provided with no reported adverse event (latency-same day) (Vaccine preparation error) (Poor quality vaccine administered). Action taken was not applicable. At time of reporting, the outcome was Unknown for the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 14.02.2023
- Impfdatum
- 10.02.2023
- Beginn
- 10.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product preparation issue
Symptomtext
No adverse events occurred to client during or after vaccines. Yellow Fever vaccine was accidentally reconstituted with incorrect diulent (sterile water). Sanofi has been contact for further instruction and client has been notified. Client does not report any adverse effects or reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- None
- Vorherige Impfungen
- -